Emerging cellular functions of cytoplasmic PML

Frontiers in Oncology

Volumn 3 JUN, Issue , 2013, Pages

  Jin, Guoxiang ^a   Wang, Ying Jan ^a,b   Lin, Hui Kuan ^a,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Antiviral response; Apoptosis; Cytoplasmic PML; TGF ; Tumorigenesis

Indexed keywords

IMMEDIATE EARLY PROTEIN; INTERFERON; PHOSPHOENOLPYRUVATE; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA;

ANTIVIRAL ACTIVITY; APOPTOSIS; CALCIUM TRANSPORT; CARCINOGENESIS; CELL CYCLE REGULATION; CELL FUNCTION; CELL NUCLEUS INCLUSION BODY; CELL PROLIFERATION; CYTOPLASM; DNA DAMAGE; ENDOPLASMIC RETICULUM; ENERGY METABOLISM; FATTY ACID OXIDATION; GLYCOLYSIS; HUMAN; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION;

EID: 84891592804     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00147     Document Type: Review

References (70)

1. Ahn, J. H., and Hayward, G. S. (1997). The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J. Virol. 71, 4599-4613.
2. Ahn, J. H., and Hayward, G. S. (2000). Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology 274, 39-55. doi:10.1006/viro.2000.0448.
3. Bell, P., Brazas, R., Ganem, D., and Maul, G. G. (2000a). Hepatitis delta virus replication generates complexes of large hepatitis delta antigen and antigenomic RNA that affiliate with and alter nuclear domain 10. J. Virol. 74, 5329-5336. doi:10.1128/JVI.74.11.5329-5336.2000.
4. Bell, P., Lieberman, P. M., and Maul, G. G. (2000b). Lytic but not latent replication of Epstein-Barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J. Virol. 74, 11800-11810. doi:10.1128/JVI.74.24.11800-11810.2000.
5. Bellodi, C. (2006). Cytoplasmic function of mutant promyelocytic leukemia (PML) and PML-retinoic acid receptor. J. Biol. Chem. 281, 14465-14473. doi:10.1074/jbc.M600457200.
6. Bellodi, C., Kindle, K., Bernassola, F., Cossarizza, A., Dinsdale, D., Melino, G., et al. (2006). A cytoplasmic PML mutant inhibits p53 function. Cell Cycle 5, 2688-2692. doi:10.4161/cc.5.22.3504.
7. Bernardi, R., Guernah, I., Jin, D., Grisendi, S., Alimonti, A., Teruya-Feldstein, J., et al. (2006). PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR. Nature 442, 779-785. doi:10.1038/nature05029.
8. Bernardi, R., and Pandolfi, P. P. (2007). Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 8, 1006-1016. doi:10.1038/nrm2277.
9. Borden, K. L., Campbell Dwyer, E. J., and Salvato, M. S. (1998). An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J. Virol. 72, 758-766.
10. Brasier, A. R., Spratt, H., Wu, Z., Boldogh, I., Zhang, Y., Garofalo, R. P., et al. (2004). Nuclear heat shock response and novel nuclear domain 10 reorganization in respiratory syncytial virus-infected a549 cells identified by high-resolution two-dimensional gel electrophoresis. J. Virol. 78, 11461-11476. doi:10.1128/JVI.78.21.11461-11476.2004.
11. Bravo, R., Vicencio, J. M., Parra, V., Troncoso, R., Munoz, J. P., Bui, M., et al. (2011). Increased ER-mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress. J. Cell. Sci. 124, 2143-2152. doi:10.1242/jcs.080762.
12. Carracedo, A., Ito, K., and Pandolfi, P. P. (2011). The nuclear bodies inside out: PML conquers the cytoplasm. Curr. Opin. Cell Biol. 23, 360-366. doi:10.1016/j.ceb.2011.03.011.
13. Carracedo, A., Weiss, D., Leliaert, A. K., Bhasin, M., de Boer, V. C., Laurent, G., et al. (2012). A metabolic prosurvival role for PML in breast cancer. J. Clin. Invest. 122, 3088-3100. doi:10.1172/JCI62129.
14. Chami, M., Oules, B., Szabadkai, G., Tacine, R., Rizzuto, R., and Paterlini-Brechot, P. (2008). Role of SERCA1 truncated isoform in the proapoptotic calcium transfer from ER to mitochondria during ER stress. Mol. Cell 32, 641-651. doi:10.1016/j.molcel.2008.11.014.
15. Chan, J. Y., Chin, W., Liew, C. T., Chang, K. S., and Johnson, P. J. (1998). Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues. Eur. J. Cancer 34, 1015-1022. doi:10.1016/S0959-8049(97)10138-1.
16. Chaneton, B., and Gottlieb, E. (2012). Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer. Trends Biochem. Sci. 37, 309-316. doi:10.1016/j.tibs.2012.04.003.
17. Chelbi-Alix, M. K., Pelicano, L., Quignon, F., Koken, M. H., Venturini, L., Stadler, M., et al. (1995). Induction of the PML protein by interferons in normal and APL cells. Leukemia 9, 2027-2033.
18. Chen, R. H., Lee, Y. R., and Yuan, W. C. (2012). The role of PML ubiquitination in human malignancies. J. Biomed. Sci. 19, 81. doi:10.1186/1423-0127-19-81.
19. de The, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., and Dejean, A. (1991). The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66, 675-684. doi:10.1016/0092-8674(91)90113-D.
20. Dellaire, G. (2006). Mitotic accumulations of PML protein contribute to the re-establishment of PML nuclear bodies in G1. J. Cell. Sci. 119, 1034-1042. doi:10.1242/jcs.02817.
21. Dellaire, G., and Bazett-Jones, D. P. (2004). PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 26, 963-977. doi:10.1002/bies.20089.
22. Dellaire, G., Ching, R. W., Dehghani, H., Ren, Y., and Bazett-Jones, D. P. (2006). The number of PML nuclear bodies increases in early S phase by a fission mechanism. J. Cell. Sci. 119, 1026-1033. doi:10.1242/jcs.02816.
23. Derynck, R., Akhurst, R. J., and Balmain, A. (2001). TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 29, 117-129. doi:10.1038/ng1001-117.
24. Doucas, V., Ishov, A. M., Romo, A., Juguilon, H., Weitzman, M. D., Evans, R. M., et al. (1996). Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 10, 196-207. doi:10.1101/gad.10.2.196.
25. Everett, R. D., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M., et al. (1998). The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J. Virol. 72, 6581-6591.
26. Faresse, N., Colland, F., Ferrand, N., Prunier, C., Bourgeade, M. F., and Atfi, A. (2008). Identification of PCTA, a TGIF antagonist that promotes PML function in TGF-beta signalling. EMBO J. 27, 1804-1815. doi:10.1038/emboj.2008.109.
27. Ferbeyre, G., de Stanchina, E., Querido, E., Baptiste, N., Prives, C., and Lowe, S. W. (2000). PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14, 2015-2027.
28. Geoffroy, M. C., and Chelbi-Alix, M. K. (2011). Role of promyelocytic leukemia protein in host antiviral defense. J. Interferon Cytokine Res. 31, 145-158. doi:10.1089/jir.2010.0111.
29. Giorgi, C., Ito, K., Lin, H. K., Santangelo, C., Wieckowski, M. R., Lebiedzinska, M., et al. (2010). PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 330, 1247-1251. doi:10.1126/science.1189157.
30. Goddard, A. D., Borrow, J., Freemont, P. S., and Solomon, E. (1991). Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254, 1371-1374. doi:10.1126/science.1720570.
31. Guo, A., Salomoni, P., Luo, J., Shih, A., Zhong, S., Gu, W., et al. (2000). The function of PML in p53-dependent apoptosis. Nat. Cell Biol. 2, 730-736. doi:10.1038/35036365.
32. Gurrieri, C. (2004). Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia. Blood 103, 2358-2362. doi:10.1182/blood-2003-07-2200.
33. Gurrieri, C., Capodieci, P., Bernardi, R., Scaglioni, P. P., Nafa, K., Rush, L. J., et al. (2004). Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J. Natl. Cancer Inst. 96, 269-279. doi:10.1093/jnci/djh043.
34. Houben, F., De Vos, W. H., Krapels, I. P., Coorens, M., Kierkels, G. J., Kamps, M. A., et al. (2013). Cytoplasmic localization of PML particles in laminopathies. Histochem. Cell Biol. 139, 119-134. doi:10.1007/s00418-012-1005-5.
35. Ito, K., Carracedo, A., Weiss, D., Arai, F., Ala, U., Avigan, D. E., et al. (2012). A PML-PPAR-delta pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance. Nat. Med. 18, 1350-1358. doi:10.1038/nm.2882.
36. Jensen, K., Shiels, C., and Freemont, P. S. (2001). PML protein isoforms and the RBCC/TRIM motif. Oncogene 20, 7223-7233. doi:10.1038/sj.onc.1204765.
37. Kakizuka, A., Miller, W. H. Jr., Umesono, K., Warrell, R. P. Jr., Frankel, S. R., Murty, V. V., et al. (1991). Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66, 663-674. doi:10.1016/0092-8674(91)90112-C.
38. Kastner, P., Perez, A., Lutz, Y., Rochette-Egly, C., Gaub, M. P., Durand, B., et al. (1992). Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J. 11, 629-642.
39. Katakura, Y., Nakata, E., Miura, T., and Shirahata, S. (1999). Transforming growth factor beta triggers two independent-senescence programs in cancer cells. Biochem. Biophys. Res. Commun. 255, 110-115. doi:10.1006/bbrc.1999.0129.
40. Kentsis, A., Dwyer, E. C., Perez, J. M., Sharma, M., Chen, A., Pan, Z. Q., et al. (2001). The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E. J. Mol. Biol. 312, 609-623. doi:10.1006/jmbi.2001.5003.
41. Korioth, F., Maul, G. G., Plachter, B., Stamminger, T., and Frey, J. (1996). The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp. Cell Res. 229, 155-158. doi:10.1006/excr.1996.0353.
42. Lavau, C., Marchio, A., Fagioli, M., Jansen, J., Falini, B., Lebon, P., et al. (1995). The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 11, 871-876.
43. Lin, D. Y., Huang, Y. S., Jeng, J. C., Kuo, H. Y., Chang, C. C., Chao, T. T., et al. (2006). Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell 24, 341-354. doi:10.1016/j.molcel.2006.10.019.
44. Lin, H. K., Bergmann, S., and Pandolfi, P. P. (2004). Cytoplasmic PML function in TGF-beta signalling. Nature 431, 205-211. doi:10.1038/nature02783.
45. Maroui, M. A., Pampin, M., and Chelbi-Alix, M. K. (2011). Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies. J. Virol. 85, 13164-13173. doi:10.1128/JVI.05808-11.
46. Martin, N., Benhamed, M., Nacerddine, K., Demarque, M. D., van Lohuizen, M., Dejean, A., et al. (2012). Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence. EMBO J. 31, 95-109. doi:10.1038/emboj.2011.370.
47. Mazurek, S. (2011). Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int. J. Biochem. Cell Biol. 43, 969-980. doi:10.1016/j.biocel.2010.02.005.
48. McNally, B. A., Trgovcich, J., Maul, G. G., Liu, Y., and Zheng, P. (2008). A role for cytoplasmic PML in cellular resistance to viral infection. PLoS ONE 3:e2277. doi:10.1371/journal.pone.0002277.
49. Mu, Z. M., Chin, K. V., Liu, J. H., Lozano, G., and Chang, K. S. (1994). PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol. 14, 6858-6867.
50. Pandolfi, P. P., Grignani, F., Alcalay, M., Mencarelli, A., Biondi, A., LoCoco, F., et al. (1991). Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6, 1285-1292.
51. Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., et al. (2000). PML regulates p53 acetylation and premature senescence induced by oncogenic ras. Nature 406, 207-210. doi:10.1038/35018127.
52. Pinton, P., Giorgi, C., Siviero, R., Zecchini, E., and Rizzuto, R. (2008). Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene 27, 6407-6418. doi:10.1038/onc.2008.308.
53. Platanias, L. C. (2005). Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375-386. doi:10.1038/nri1604.
54. Puvion-Dutilleul, F., Chelbi-Alix, M. K., Koken, M., Quignon, F., Puvion, E., and de The, H. (1995a). Adenovirus infection induces rearrangements in the intranuclear distribution of the nuclear body-associated PML protein. Exp. Cell Res. 218, 9-16. doi:10.1006/excr.1995.1125.
55. Puvion-Dutilleul, F., Venturini, L., Guillemin, M. C., de The, H., and Puvion, E. (1995b). Sequestration of PML and Sp100 proteins in an intranuclear viral structure during herpes simplex virus type 1 infection. Exp. Cell Res. 221, 448-461. doi:10.1006/excr.1995.1396.
56. Scaglioni, P. P., Yung, T. M., Cai, L. F., Erdjument-Bromage, H., Kaufman, A. J., Singh, B., et al. (2006). A CK2-dependent mechanism for degradation of the PML tumor suppressor. Cell 126, 269-283. doi:10.1016/j.cell.2006.05.041.
57. Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., et al. (2009). Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461, 109-113. doi:10.1038/nature08268.
58. Seo, S. R., Ferrand, N., Faresse, N., Prunier, C., Abecassis, L., Pessah, M., et al. (2006). Nuclear retention of the tumor suppressor cPML by the homeodomain protein TGIF restricts TGF-beta signaling. Mol. Cell 23, 547-559. doi:10.1016/j.molcel.2006.06.018.
59. Shimada, N., Shinagawa, T., and Ishii, S. (2008). Modulation of M2-type pyruvate kinase activity by the cytoplasmic PML tumor suppressor protein. Genes Cells 13, 245-254. doi:10.1111/j.1365-2443.2008.01165.x.
60. Siegel, P. M., and Massague, J. (2003). Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 3, 807-821. doi:10.1038/nrc1208.
61. Terris, B., Baldin, V., Dubois, S., Degott, C., Flejou, J. F., Henin, D., et al. (1995). PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res. 55, 1590-1597.
62. Trotman, L. C., Alimonti, A., Scaglioni, P. P., Koutcher, J. A., Cordon-Cardo, C., and Pandolfi, P. P. (2006). Identification of a tumour suppressor network opposing nuclear akt function. Nature 441, 523-527. doi:10.1038/nature04809.
63. Turelli, P., Doucas, V., Craig, E., Mangeat, B., Klages, N., Evans, R., et al. (2001). Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol. Cell 7, 1245-1254. doi:10.1016/S1097-2765(01)00255-6.
64. Vernier, M., Bourdeau, V., Gaumont-Leclerc, M. F., Moiseeva, O., Begin, V., Saad, F., et al. (2011). Regulation of E2Fs and senescence by PML nuclear bodies. Genes Dev. 25, 41-50. doi:10.1101/gad.1975111.
65. Wang, Z. G., Delva, L., Gaboli, M., Rivi, R., Giorgio, M., Cordon-Cardo, C., et al. (1998a). Role of PML in cell growth and the retinoic acid pathway. Science 279, 1547-1551. doi:10.1126/science.279.5356.1547.
66. Wang, Z. G., Ruggero, D., Ronchetti, S., Zhong, S., Gaboli, M., Rivi, R., et al. (1998b). PML is essential for multiple apoptotic pathways. Nat. Genet. 20, 266-272. doi:10.1038/3030.
67. Zaugg, K., Yao, Y., Reilly, P. T., Kannan, K., Kiarash, R., Mason, J., et al. (2011). Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev. 25, 1041-1051. doi:10.1101/gad.1987211.
68. Zheng, P., Guo, Y., Niu, Q., Levy, D. E., Dyck, J. A., Lu, S., et al. (1998). Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature 396, 373-376. doi:10.1038/24628.
69. Zhong, S., Hu, P., Ye, T. Z., Stan, R., Ellis, N. A., and Pandolfi, P. P. (1999). A role for PML and the nuclear body in genomic stability. Oncogene 18, 7941-7947. doi:10.1038/sj.onc.1203367.
70. Zhong, S., Muller, S., Ronchetti, S., Freemont, P. S., Dejean, A., and Pandolfi, P. P. (2000). Role of SUMO-1-modified PML in nuclear body formation. Blood 95, 2748-2752.